We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Moves -0.14%: What You Should Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed at $522.80 in the latest trading session, marking a -0.14% move from the prior day. This change was narrower than the S&P 500's daily loss of 1.13%. At the same time, the Dow lost 1.01%, and the tech-heavy Nasdaq lost 0.07%.
Heading into today, shares of the largest U.S. health insurer had lost 3.86% over the past month, outpacing the Medical sector's loss of 4.89% and the S&P 500's loss of 7.59% in that time.
UnitedHealth Group will be looking to display strength as it nears its next earnings release, which is expected to be October 14, 2022. The company is expected to report EPS of $5.45, up 20.58% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $80.71 billion, up 11.58% from the prior-year quarter.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $21.85 per share and revenue of $322.11 billion. These results would represent year-over-year changes of +14.88% and +12%, respectively.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.11% lower. UnitedHealth Group is currently sporting a Zacks Rank of #3 (Hold).
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 23.96. Its industry sports an average Forward P/E of 19.47, so we one might conclude that UnitedHealth Group is trading at a premium comparatively.
It is also worth noting that UNH currently has a PEG ratio of 1.64. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.16 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 167, which puts it in the bottom 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Stock Moves -0.14%: What You Should Know
UnitedHealth Group (UNH - Free Report) closed at $522.80 in the latest trading session, marking a -0.14% move from the prior day. This change was narrower than the S&P 500's daily loss of 1.13%. At the same time, the Dow lost 1.01%, and the tech-heavy Nasdaq lost 0.07%.
Heading into today, shares of the largest U.S. health insurer had lost 3.86% over the past month, outpacing the Medical sector's loss of 4.89% and the S&P 500's loss of 7.59% in that time.
UnitedHealth Group will be looking to display strength as it nears its next earnings release, which is expected to be October 14, 2022. The company is expected to report EPS of $5.45, up 20.58% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $80.71 billion, up 11.58% from the prior-year quarter.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $21.85 per share and revenue of $322.11 billion. These results would represent year-over-year changes of +14.88% and +12%, respectively.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.11% lower. UnitedHealth Group is currently sporting a Zacks Rank of #3 (Hold).
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 23.96. Its industry sports an average Forward P/E of 19.47, so we one might conclude that UnitedHealth Group is trading at a premium comparatively.
It is also worth noting that UNH currently has a PEG ratio of 1.64. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.16 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 167, which puts it in the bottom 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.